Evidence map›Paper›PMID 37728818›Full record

ArticleClinical and experimental medicine2023

Assessment of α

Pınar Ellergezen, Belkıs Nihan Coşkun, Gülce Sevdar Çeçen, Zeynep Yılmaz Bozkurt, Harun Ağca, Hüseyin Ediz Dalkılıç, Sinan Çavun

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Behçet's Syndrome.Current rheumatology reports · 2026
    Review
  2. α9β1 integrin & its ligands as new potential biomarkers in FMF.The Indian journal of medical research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Pınar EllergezenBursa Uludag University Faculty of Medicine, Department of Medical Pharmacology, Bursa Uludag University, Gorukle Campus, 16059, Nilufer-Bursa, Turkey. pinarhiz@gmail.com.ORCID http://orcid.org/0000-0003-3419-1995
Belkıs Nihan CoşkunBursa Uludag University Faculty of Medicine, Department of Rheumatology, Bursa Uludag University, Gorukle Campus, 16059, Nilufer-Bursa, Turkey.ORCID http://orcid.org/0000-0003-0298-4157
Gülce Sevdar ÇeçenBursa Uludag University Faculty of Medicine, Department of Medical Pharmacology, Bursa Uludag University, Gorukle Campus, 16059, Nilufer-Bursa, Turkey.ORCID http://orcid.org/0000-0003-0307-3486
Zeynep Yılmaz BozkurtBursa Uludag University Faculty of Medicine, Department of Rheumatology, Bursa Uludag University, Gorukle Campus, 16059, Nilufer-Bursa, Turkey.ORCID http://orcid.org/0000-0003-3612-3232
Harun AğcaBursa Uludag University Faculty of Medicine, Department of Medical Microbiology, Bursa Uludag University, Gorukle Campus, 16059, Nilufer-Bursa, Turkey.ORCID http://orcid.org/0000-0002-2651-2034
Hüseyin Ediz DalkılıçBursa Uludag University Faculty of Medicine, Department of Rheumatology, Bursa Uludag University, Gorukle Campus, 16059, Nilufer-Bursa, Turkey.ORCID http://orcid.org/0000-0001-8645-2670
Sinan ÇavunBursa Uludag University Faculty of Medicine, Department of Medical Pharmacology, Bursa Uludag University, Gorukle Campus, 16059, Nilufer-Bursa, Turkey.ORCID http://orcid.org/0000-0003-0764-6376
Bursa Uludağ Üni̇versi̇tesi̇ · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the roles of α9β1 integrin and its ligands in Behçet's disease (BD) by examining serum levels and gene expressions. 15 healthy controls and 30 BD patients (14 active and 16 inactive) were included in the study. Serum levels of ITGA9, ITGB1, TNC, OPN, VCAM-1, VEGF, TSP1, TGM2, Emilin-1, and vWF, were measured by ELISA. Gene expressions of α9β1 (ITGA9 and ITGB1) and its ligands (TNC and SPP1) were evaluated by RT-PCR. Laboratory findings (CRP, ESR, HGB, WBC, RBC, neutrophil, lymphocyte, PLT, RDW, MPV, PCT, and HLA-B51) were obtained from the electronic database. Active BD patients had higher serum levels of α

Indexed as

Behcet SyndromeBiomarkersCase-Control StudiesHumansIntegrinsLymphocytesBiomarkersIntegrinsActiveBehcetİnactiveİntegrinLigandss diseaseα9β1

Identifiers

PMID37728818
OpenAlexW4386878741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.